| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1001774064 |
| P356 | DOI | 10.1186/S12957-015-0703-6 |
| P932 | PMC publication ID | 4618525 |
| P698 | PubMed publication ID | 26493405 |
| P5875 | ResearchGate publication ID | 283209581 |
| P50 | author | Simone Sibio | Q63379104 |
| Paolo Sammartino | Q67954757 | ||
| Daniela Musio | Q56496351 | ||
| Daniele Biacchi | Q56816681 | ||
| P2093 | author name string | Angelo Di Giorgio | |
| Fabio Accarpio | |||
| Maurizio Cardi | |||
| Bianca Sollazzo | |||
| Valentina Mingarelli | |||
| P2860 | cites work | Peritoneal Sarcomatosis: Is There a Subset of Patients Who May Benefit from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy? | Q63197829 |
| Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors | Q69935981 | ||
| Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study | Q73368601 | ||
| Metastatic breast carcinoma to the abdomen and pelvis | Q73538483 | ||
| Intraperitoneal cancer dissemination: mechanisms of the patterns of spread | Q73717013 | ||
| Breast cancer metastatic to abdomen and pelvis: role of surgical resection | Q73739427 | ||
| Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer | Q79150738 | ||
| Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center | Q80199761 | ||
| Breast cancer (metastatic) | Q80262654 | ||
| Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of recurrent endometrial carcinoma confined to the peritoneal cavity | Q82040970 | ||
| Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy | Q83903423 | ||
| Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: non-colorectal indications | Q84332645 | ||
| Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer | Q84529939 | ||
| Initial experience with hyperthermic intraperitoneal chemotherapy | Q85335247 | ||
| Neuroendocrine carcinomas: optimal surgery of peritoneal metastases (and associated intra-abdominal metastases) | Q86423600 | ||
| Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors | Q29618610 | ||
| Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy | Q34276733 | ||
| Mucinous adenocarcinoma of the small bowel with peritoneal seeding | Q34546221 | ||
| Natural history of peritoneal carcinomatosis from nongynecologic malignancies. | Q35563265 | ||
| Prevention of Peritoneal Metastases from Colon Cancer in High-Risk Patients: Preliminary Results of Surgery plus Prophylactic HIPEC. | Q35974935 | ||
| Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma | Q36199837 | ||
| The consensus statement on the locoregional treatment of abdominal sarcomatosis. | Q37252051 | ||
| Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review | Q37319775 | ||
| Outcomes of Cytoreductive Surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality | Q37438208 | ||
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma | Q37438233 | ||
| Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma | Q37526718 | ||
| Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results | Q37585146 | ||
| Morbidity and mortality of 109 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC) performed at a community hospital | Q37658497 | ||
| Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients | Q37662806 | ||
| Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosis | Q37670384 | ||
| Updates on the multimodality management of desmoplastic small round cell tumor | Q37973027 | ||
| Current status and future directions of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer | Q38047549 | ||
| Small bowel cancer: epidemiological and clinical characteristics from a population-based registry | Q40747306 | ||
| Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. | Q41146040 | ||
| Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis | Q41741362 | ||
| Cytoreductive surgery plus hyperthermic perioperative chemotherapy for selected patients with peritoneal metastases from colorectal cancer: a new standard of care or an experimental approach? | Q41902566 | ||
| Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. | Q42655076 | ||
| Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients | Q43421690 | ||
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. | Q43703526 | ||
| Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosis | Q43744936 | ||
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial. | Q43765205 | ||
| Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of endometrial cancer with peritoneal carcinomatosis. | Q43922824 | ||
| Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. | Q43932503 | ||
| Tumor volume as a prognostic factor for sarcomatosis | Q44388061 | ||
| Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion | Q45288550 | ||
| Treatment of peritoneal carcinomatosis from breast cancer by maximal cytoreduction and HIPEC: a preliminary report on 5 cases. | Q45388842 | ||
| Abdominal carcinomatosis attributed to metastatic breast carcinoma. | Q51682535 | ||
| Peritoneal Surface Disease Severity Score as a predictor of resectability in the treatment of peritoneal surface malignancies. | Q54337800 | ||
| P921 | main subject | peritoneal carcinomatosis | Q2071182 |
| P304 | page(s) | 305 | |
| P577 | publication date | 2015-10-22 | |
| P1433 | published in | World Journal of Surgical Oncology | Q14520241 |
| P1476 | title | Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis | |
| P478 | volume | 13 |
| Q90681958 | Peritoneal Metastases from Breast Cancer: A Scoping Review |
| Q92700809 | Prognostic Factors Influencing Infectious Complications after Cytoreductive Surgery and HIPEC: Results from a Tertiary Referral Center |
| Q92617988 | Uncommon indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
Search more.